0000899243-20-027918.txt : 20201009
0000899243-20-027918.hdr.sgml : 20201009
20201009172358
ACCESSION NUMBER: 0000899243-20-027918
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201007
FILED AS OF DATE: 20201009
DATE AS OF CHANGE: 20201009
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valle Franco
CENTRAL INDEX KEY: 0001699848
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38533
FILM NUMBER: 201233989
MAIL ADDRESS:
STREET 1: 999 SKYWAY ROAD, SUITE 150
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eidos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001731831
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463733671
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-391-9740
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-07
0
0001731831
Eidos Therapeutics, Inc.
EIDX
0001699848
Valle Franco
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2000
SAN FRANCISCO
CA
94104
0
1
0
0
Senior Vice President, Finance
Common Stock
2020-10-07
4
M
0
5000
7.24
A
5444
D
Common Stock
2020-10-07
4
S
0
5444
75.0823
D
0
D
Common Stock
2020-10-08
4
M
0
5199
7.24
A
5199
D
Common Stock
2020-10-08
4
S
0
5199
74.8511
D
0
D
Stock Option (Right to Buy)
7.24
2020-10-07
4
M
0
5000
0.00
D
2028-05-06
Common Stock
5000
34419
D
Stock Option (Right to Buy)
7.24
2020-10-08
4
M
0
5199
0.00
D
2028-05-06
Common Stock
5199
29220
D
Represents the weighted average sale price of the shares sold from $74.9701 to $75.3901 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2.
Represents the weighted average sale price of the shares sold from $74.77 to $74.95 per share.
The option, originally representing a right to purchase a total of 77,919 shares, vested and became exercisable as to 25% of the original option on March 28, 2019, and the remainder vests in 36 additional monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer.
/s/ Franco Valle
2020-10-09